vimarsana.com

Page 7 - அல்கொன்கின் பவர் பயன்பாடுகள் கார்ப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The critics weigh in on the model dividend portfolio

The Globe and Mail Published April 17, 2021 John Minchillo/The Associated Press I just finished reading your April 10 update about your model Yield Hog Dividend Growth Portfolio. To me the praise for the strategy is skewed and disingenuous. Since October, 2017, the portfolio is up about 38 per cent on a total return basis, while the S&P 500 is up 74 per cent. There are people following the advice from this strategy who have left huge gains on the table. Do an honest comparison so people can make the best decisions with their money. Yes, the S&P 500 has left my model portfolio in the dust in recent years. I’ve been quite open about that: Google “Why I’m not giving up on dividends – and you shouldn’t either.” But I’m glad you brought it up, because it gives me a chance to remind readers of a few points I have raised in previous columns.

Wednesday s analyst upgrades and downgrades - The Globe and Mail

The Globe and Mail Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account Getting audio file . This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer Inside the Market’s roundup of some of today’s key analyst actions CIBC downgraded Organigram Holdings Inc. (OGI-T) to an “underperformer” rating - the equivalent of a sell recommendation - from “neutral”, and was among several brokers that slashed price targets on the cannabis company following disappointing quarterly results. Organigram said Tuesday it had a net loss of $66.4 million (Canadian) in its fiscal second quarter to Feb. 28, wider than the loss of $6.8 million posted in the year-earlier quarter. Revenue fell to $14.6 million from $23.2 million, missing the Street consensus of $19.1 million. Revenue was hurt by missed sales opportunities as a “significant number” of staff had to isolat

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.